Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)
Recruiting
N/A
Interventional Study
Stroke, Acute
Stroke
Stroke, Cardiovascular
Stroke (CVA) or TIA
Stroke/Brain Attack
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 85
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 94 (estimated)
- Sponsor
- Baylor Research Institute · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Investigators will conduct a randomized controlled trial (RCT) to assess intervention efficacy of telehealth delivery of the GLB-CVA (tGLB-CVA) compared to a 6-month wait-list control (WLC) in partnership with a diverse group of patient partners and peer mentors.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Body Mass Index ≥25
* All types of stroke
* Able to Participate in Physical Activity
* ≥12 months post first stroke
* Have internet, phone, or computer access, or be willing to use one provided by the study team
Exclusion Criteria:
* Contraindications for physical activity
*…
Contacts
No contact information available.